Search Results - "AMROLIA, Persis J"
-
1
Impact of thymoglobulin prior to pediatric unrelated umbilical cord blood transplantation on immune reconstitution and clinical outcome
Published in Blood (02-01-2014)“…In vivo T-cell depletion might contribute to the delayed immune reconstitution observed after unrelated umbilical cord blood transplantation (UCBT). We studied…”
Get full text
Journal Article -
2
Proposed Therapeutic Range of Treosulfan in Reduced Toxicity Pediatric Allogeneic Hematopoietic Stem Cell Transplant Conditioning: Results From a Prospective Trial
Published in Clinical pharmacology and therapeutics (01-08-2020)“…Treosulfan is given off‐label in pediatric allogeneic hematopoietic stem cell transplant. This study investigated treosulfan's pharmacokinetics (PKs),…”
Get full text
Journal Article -
3
How I treat severe combined immunodeficiency
Published in Blood (28-11-2013)“…Severe combined immunodeficiency (SCID) arises from different genetic defects associated with lymphocyte development and function and presents with severe…”
Get full text
Journal Article -
4
Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomes
Published in Blood (07-02-2013)“…There have been no studies on patient outcome after allogeneic hematopoietic cell transplantation (HCT) in patients with X-linked inhibitor of apoptosis (XIAP)…”
Get full text
Journal Article -
5
Epstein–Barr virus (EBV) deletions as biomarkers of response to treatment of chronic active EBV
Published in British journal of haematology (01-10-2021)“…Summary Chronic active Epstein–Barr virus (CAEBV) disease is a rare condition characterised by persistent EBV infection in previously healthy individuals…”
Get full text
Journal Article -
6
Epstein-Barr Virus Reactivation After Paediatric Haematopoietic Stem Cell Transplantation: Risk Factors and Sensitivity Analysis of Mathematical Model
Published in Frontiers in immunology (12-07-2022)“…Epstein-Barr virus (EBV) establishes a lifelong latent infection in healthy humans, kept under immune control by cytotoxic T cells (CTLs). Following paediatric…”
Get full text
Journal Article -
7
Cord blood transplantation recapitulates fetal ontogeny with a distinct molecular signature that supports CD4+ T-cell reconstitution
Published in Blood advances (14-11-2017)“…Omission of in vivo T-cell depletion promotes rapid, thymic-independent CD4+-biased T-cell recovery after cord blood transplant. This enhanced T-cell…”
Get full text
Journal Article -
8
High-dimensional functional phenotyping of preclinical human CAR T cells using mass cytometry
Published in STAR protocols (18-03-2022)“…Here, we present a comprehensive protocol for the generation and functional characterization of chimeric antigen receptor (CAR) T cells and their products by…”
Get full text
Journal Article -
9
Allogeneic hematopoietic stem cell transplantation for severe, refractory juvenile idiopathic arthritis
Published in Blood advances (10-04-2018)“…Patients with juvenile idiopathic arthritis (JIA) can experience a severe disease course, with progressive destructive polyarthritis refractory to conventional…”
Get full text
Journal Article -
10
Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR
Published in Nature medicine (01-09-2019)“…Chimeric antigen receptor (CAR)-modified T cells targeting CD19 demonstrate unparalleled responses in relapsed/refractory acute lymphoblastic leukemia (ALL) 1…”
Get full text
Journal Article -
11
Betibeglogene Autotemcel Gene Therapy for Non–β0/β0 Genotype β-Thalassemia
Published in The New England journal of medicine (03-02-2022)“…Of 23 patients with transfusion-dependent β-thalassemia who received gene-transfected autologous hematopoietic cells, 91% became transfusion independent; the…”
Get full text
Journal Article -
12
CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial
Published in Nature medicine (01-10-2021)“…Chimeric antigen receptor (CAR) T cells targeting CD19 or CD22 have shown remarkable activity in B cell acute lymphoblastic leukemia (B-ALL). The major cause…”
Get full text
Journal Article -
13
Transcriptional signatures associated with persisting CD19 CAR-T cells in children with leukemia
Published in Nature medicine (01-07-2023)“…In the context of relapsed and refractory childhood pre-B cell acute lymphoblastic leukemia (R/R B-ALL), CD19-targeting chimeric antigen receptor (CAR)-T cells…”
Get full text
Journal Article -
14
Chimeric antigen receptor T cells for ALL
Published in The Lancet (British edition) (07-02-2015)“…In adult patients, relapse is more frequent and often unsalvageable. Since such patients have often had the maximum tolerable dose of chemotherapy and…”
Get full text
Journal Article -
15
Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
Published in Blood (04-02-2010)“…T-cell immunotherapy that takes advantage of Epstein-Barr virus (EBV)–stimulated immunity has the potential to fill an important niche in targeted therapy for…”
Get full text
Journal Article -
16
Practice guideline: Preparation for CAR T‐cell therapy in children and young adults with B‐acute lymphoblastic leukaemia
Published in British journal of haematology (01-05-2024)“…Summary The objective of this guideline, prepared by the ALL subgroup of the Advanced Cell Therapy Sub‐Committee of BSBMTCT (British Society of Blood and…”
Get full text
Journal Article -
17
Similar outcome of upfront‐unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT
Published in British journal of haematology (01-11-2015)“…Summary We explored the feasibility of unrelated donor haematopoietic stem cell transplant (HSCT) upfront without prior immunosuppressive therapy (IST) in…”
Get full text
Journal Article -
18
Clonal expansion of T memory stem cells determines early anti-leukemic responses and long-term CAR T cell persistence in patients
Published in Nature cancer (01-06-2021)“…Low-affinity CD19 chimeric antigen receptor (CAR) T cells display enhanced expansion and persistence, enabling fate tracking through integration site analysis…”
Get full text
Journal Article -
19
Towards gene therapy for EBV-associated posttransplant lymphoma with genetically modified EBV-specific cytotoxic T cells
Published in Blood (16-10-2014)“…Epstein-Barr virus (EBV)-associated posttransplant lymphoma (PTLD) is a major cause of morbidity/mortality after hematopoietic stem cell (SCT) or solid organ…”
Get full text
Journal Article -
20
CD19/CD22 targeting with cotransduced CAR T cells to prevent antigen-negative relapse after CAR T-cell therapy for B-cell ALL
Published in Blood (11-01-2024)“…CD19-negative relapse is a leading cause of treatment failure after chimeric antigen receptor (CAR) T-cell therapy for acute lymphoblastic leukemia. We…”
Get full text
Journal Article